Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics

Mycoses

Volumn 46, Issue 9-10, 2003, Pages 365-369

  Mendling, W ^a,c   Seebacher, C ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^c VIVANTES KLINIKUM AM URBAN   (Germany)

Author keywords

Candida; Candidosis; Vulvovaginal infection

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BORIC ACID; CICLOPIROXOLAMINE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; POLYENE ANTIBIOTIC AGENT; TRIAZOLE DERIVATIVE;

CANDIDA ALBICANS; DIFFERENTIAL DIAGNOSIS; FEMALE; FUNGUS CULTURE; GERMANY; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VAGINA CANDIDIASIS; VULVOVAGINITIS;

CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TERMINOLOGY;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0242635606     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0933-7407.2003.00909.x     Document Type: Review

References (22)

1. Odds FC, Arai T, Disalvo AF et al. Nomenclature of fungal diseases: a report and recommendations from a subcommittee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992; 30: 1-10.
2. Mendling W. Vaginose. Vaginitis und Zervizitis. Berlin-Heidelberg-New York: Springer, 1995.
3. Mendling W, Pinto Andrade de M, Gutschmidt J, Gantenberg R, Presber W, Schönian G. Strain specifity of yeasts isolated from different locations of women suffering from vaginal candidosis, and their partners. Mycoses 2000; 43: 387-92.
4. Sullivan DJ, Westerneng TJ, Haynes KS, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a new species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507-21.
5. Mendling W. Die Vulvovaginalcandidose. Gynäkologie und Geburtshilfe 1991; 4: 209-10.
6. Müller J, Nold B. Quantitative Aspekte der vaginalen Mykoflora und ihre Beziehungen zur klinischen Symptomatik bei Kolpitis-Patientinnen. In: Seeliger HPR (Hrsg) (ed.). Gyno-Travogen-Monographie. Amsterdam: Excerpta Medica. 1981: 21-30.
7. Schnell JD. Vaginalmykose und perinatale Pilzinfektion. Basel: S Karger, 1987.
8. Friese K, Mendling W. Therapie der vaginalen Mykosen - oral vs. lokal. Gynäkologe 1996; 29: 221-28.
9. Tietz HJ, Mendling W. Haut-und Vaginalmykosen. Berlin: Blackwell, 2001.
10. Nolting S, Seebacher C. Ciclopyroxolamin; Wegweiser topischer Mykose-Therapie. Jena: Universitätsverlag Jena GmbH, 1993.
11. Tietz HJ. Ciclopyroxalamin in der Therapie bei akuten und chronisch rezidivierenden Kandidosen. Gyne 2001; 4: 1-4.
12. Sobel JD. Vulvovaginitis due to Candida glabrata. An emerging problem. Review Article. Mycoses 1998; 41 (Suppl. 2): 18-22.
13. Dupont B, Improvisi J, Dromer F. Recurrent vulvovaginal candidiasis (RVVC) due to Candida albicans: epidemiology and treatment with fluconazole. Buenos Aires: 14th ISHAM Congress. 2000 (Abstract 178).
14. Kunzelmann V, Tietz HJ. Roßner D et al. Voraussetzungen für eine effektive Therapie chronisch rezidivierender Vaginalcandidosen. Mycoses 1996; 39 (Suppl. 1): 65-72.
15. Mendling W, Koldovsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Inf Dis Obstet Gynecol 1996; 4: 225-31.
16. Fidel PL, Ginsburgh KA, Cutright JL et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th-1-type responses following intravaginal challenge with Candida antigen. J Inf Dis 1997; 176: 728-39.
17. Bernhard H. Candida in Ökosystem des Orointestinaltraktes. Mycoses 1996; 39: 44-47.
18. Blaschke-Hellmessen R. Experimentelle Untersuchungen zur Epidemiologie der Hefepilzerkrankungen bei Säuglingen und Kleinkindern. Mykosen 1972; 15: 23-26.
19. Hoppe E. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J 1997; 16: 885-94.
20. Mendling W, Spitzbart H. Empfehlungen zur antimykotischen Therapie der vaginalen Hefepilz-Kolonisation der Schwangeren zur Verhütung von Candidamykosen beim Neugeborenen. Frauenarzt 1994; 1: 35-36.
21. Laskus A, Mendling W, Runge K, Schmidt A. Ist die Candida- Septikämie bei Frühgeborenen eine nosokomiale Infektion? Mycoses 1998; 41 (Suppl. 2): 37-40.
22. Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003; 63: 1059-66.